keyword
https://read.qxmd.com/read/38187875/in-silico-analysis-of-virulence-factors-of-streptococcus-uberis-for-a-chimeric-vaccine-design
#21
JOURNAL ARTICLE
Çiğdem Yılmaz Çolak
Streptococcus uberis is one of the causative agents of bovine mastitis, which has detrimental effects on animal health and the dairy industry. Despite decades of research, the requirement for effective vaccines against the disease remains unmet. The goal of this study was to create a multi-epitope vaccine using five virulence factors of S . uberis through the reverse vaccinology approach, which has been employed due to its high efficiency and applicability. Plasminogen activator A (PauA), glyceraldehyde-3-phosphate dehydrogenase C (GapC), C5a peptidase, S ...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38187223/reverse-vaccinology-and-immunoinformatics-approach-to-design-a-chimeric-epitope-vaccine-against-orientia-tsutsugamushi
#22
JOURNAL ARTICLE
Anutee Dolley, Himanshu Ballav Goswami, Dikshita Dowerah, Upalabdha Dey, Aditya Kumar, Vanlal Hmuaka, Rupak Mukhopadhyay, Debasree Kundu, George M Varghese, Robin Doley, Ramesh Chandra Deka, Nima D Namsa
Scrub typhus is a vector-borne infectious disease caused by Orientia tsutsugamushi and it is reportedly associated with up to 20 % of hospitalized cases of febrile illnesses. The major challenge of vaccine development is the lack of identified antigens that can induce both heterotypic and homotypic immunity including the production of antibodies, cytotoxic T lymphocyte, and helper T lymphocytes. We employed a comprehensive immunoinformatic prediction algorithm to identify immunogenic epitopes of the 56-kDa type-specific cell membrane surface antigen and surface cell antigen A of O ...
January 15, 2024: Heliyon
https://read.qxmd.com/read/38151110/in-silico-designing-and-characterization-of-outer-membrane-protein-k-ompk-from-vibrio-anguillarum-and-its-expression-in-nicotiana-tabacum-for-the-development-of-a-plant-based-vaccine-against-fish-vibriosis
#23
JOURNAL ARTICLE
Muhammad Suleman Malik, Iqra Elahi, Muhammad Sameeullah, Fatima Ijaz, Neelam Batool, Fatima Khalid, Ekrem Gurel, Kiran Saba, Mohammad Tahir Waheed
Vibriosis is caused by Vibrio anguillarum in various species of aquaculture. A novel, secure, and stable vaccine is needed to eradicate vibriosis. Here, for reverse vaccinology and plant-based expression, the outer membrane protein K (OmpK) of V. anguillarum was chosen due to its conserved nature in all Vibrio species. OmpK, an ideal vaccine candidate against vibriosis demonstrated immunogenic, non-allergic, and non-toxic behavior by using various bioinformatics tools. Docking showed the interaction of the OmpK model with TLR-5...
December 25, 2023: Journal of Biotechnology
https://read.qxmd.com/read/38145757/broadly-neutralizing-antibodies-to-combat-influenza-virus-infection
#24
REVIEW
Xiaoyu Sun, Hanwen Ma, Xuanjia Wang, Zhiheng Bao, Shubing Tang, Chunyan Yi, Bing Sun
The diversified classification and continuous alteration of influenza viruses underscore for antivirals and vaccines that can counter a broad range of influenza subtypes. Hemagglutinin (HA) and neuraminidase (NA) are two principle viral surface targets for broadly neutralizing antibodies. A series of monoclonal antibodies, targeting HA and NA, have been discovered and characterized with a wide range of neutralizing activity against influenza viruses. Clinical studies have demonstrated the safety and efficacy of some HA stem-targeting antibodies against influenza viruses...
December 23, 2023: Antiviral Research
https://read.qxmd.com/read/38143752/design-of-a-novel-multi-epitopes-vaccine-against-escherichia-fergusonii-a-pan-proteome-based-in-silico-approach
#25
JOURNAL ARTICLE
Taghreed N Almanaa
Escherichia fergusonii a gram-negative rod-shaped bacterium in the Enterobacteriaceae family, infect humans, causing serious illnesses such as urinary tract infection, cystitis, biliary tract infection, pneumonia, meningitis, hemolytic uremic syndrome, and death. Initially treatable with penicillin, antibiotic misuse led to evolving resistance, including resistance to colistin, a last-resort drug. With no licensed vaccine, the study aimed to design a multi-epitope vaccine against E. fergusonii . The study started with the retrieval of the complete proteome of all known strains and proceeded to filter the surface exposed virulent proteins...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38129801/unveiling-promising-immunogenic-targets-in-coxiella-burnetii-through-in-silico-analysis-paving-the-way-for-novel-vaccine-strategies
#26
JOURNAL ARTICLE
Mansoor Kodori, Jafar Amani, Ali Ahmadi
BACKGROUND: Coxiella burnetii, an intracellular pathogen, serves as the causative agent of zoonotic Q fever. This pathogen presents a significant threat due to its potential for airborne transmission, environmental persistence, and pathogenicity. The current whole-cell vaccine (WCV) utilized in Australia to combat Q fever exhibits notable limitations, including severe adverse reactions and limited regulatory approval for human use. This research employed the reverse vaccinology (RV) approach to uncover antigenic proteins and epitopes of C...
December 21, 2023: BMC Infectious Diseases
https://read.qxmd.com/read/38117103/-in-silico-development-of-multi-epitope-subunit-vaccine-against-lymphatic-filariasis
#27
REVIEW
Pratik Singh, Samir Shaikh, Sakshi Gupta, Reeshu Gupta
The World Health Organization in 2022 reported that more than 863 million people in 50 countries are at risk of developing lymphatic filariasis (LF), a disease caused by parasitic infection. Immune responses to parasites suggest that the development of a prophylactic vaccine against LF is possible. Using a reverse vaccinology approach, the current study identified Trehalose-6-phosphatase (TPP) as a potential vaccine candidate among 15 reported vaccine antigens for B. malayi . High-ranking B and T-cell epitopes in the Trehalose-6-phosphatase (TPP) were shortlisted using online servers for subsequent analysis...
December 20, 2023: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38113688/a-multi-epitope-subunit-vaccine-based-on-cu-zn-sod-omp31-and-bp26-against-brucella-melitensis-infection-in-balb-c-mice
#28
JOURNAL ARTICLE
Yueli Wang, Aodi Wu, Zhenyu Xu, Huan Zhang, Honghuan Li, Shuangshuang Fu, Yajing Liu, Lijin Cui, Yuhe Miao, Yong Wang, Kaiat Zhumanov, Yimei Xu, Jinliang Sheng, Jihai Yi, Chuangfu Chen
Brucellosis, a zoonosis caused by Brucella, is highly detrimental to both humans and animals. Most existing vaccines are live attenuated vaccines with safety flaws for people and animals. Therefore, it is advantageous to design a multi-epitope subunit vaccine (MEV) to prevent Brucella infection. To this end, we applied a reverse vaccinology approach. Six cytotoxic T cell (CTL) epitopes, seven T helper cell (HTL) epitopes, and four linear B cell epitopes from CU/ZN-SOD, Omp31, and BP26 were obtained. We linked the CTL, HTL, B-cell epitopes, the appropriate CTB molecular adjuvant, and the universal T helper lymphocyte epitope, PADRE, with linkers AAY, GPPGG, and KK, respectively...
December 18, 2023: International Immunopharmacology
https://read.qxmd.com/read/38112302/design-of-a-multi-epitope-vaccine-vme-vac-mst-1-against-cholera-and-vibriosis-based-on-reverse-vaccinology-and-immunoinformatics-approaches
#29
JOURNAL ARTICLE
Pedro Henrique Marques, Thais Cristina Vilela Rodrigues, Eduardo Horta Santos, Lucas Bleicher, Flavia Figueira Aburjaile, Flaviano S Martins, Carlo Jose Freire Oliveira, Vasco Azevedo, Sandeep Tiwari, Siomar Soares
Vibriosis and cholera are serious diseases distributed worldwide and caused by six marine bacteria of the Vibrio genus. Thousands of deaths occur each year due to these illnesses, necessitating the development of new preventive measures. Presently, the existing cholera vaccine demonstrates an effectiveness of approximately 60%. Here we describe a new multi-epitope vaccine, 'vme-VAC/MST-1' based on vaccine targets identified by reverse vaccinology and epitopes predicted by immunoinformatics, two currently effective tools for predicting new vaccines for bacterial pathogens...
December 19, 2023: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38104690/rational-design-of-a-multivalent-vaccine-targeting-arthropod-borne-viruses-using-reverse-vaccinology-strategies
#30
JOURNAL ARTICLE
T Dhanushkumar, Prasanna Kumar Selvam, Santhosh M E, Karthick Vasudevan, George Priya Doss C, Hatem Zayed, Balu Kamaraj
Viruses transmitted by arthropods, such as Dengue, Zika, and Chikungunya, represent substantial worldwide health threats, particularly in areas like India. The lack of approved vaccines and effective antiviral therapies calls for developing innovative strategies to tackle these arboviruses. In this study, we employed immunoinformatics methodologies, incorporating reverse vaccinology, to design a multivalent vaccine targeting the predominant arboviruses. Epitopes of B and T cells were recognized within the non-structural proteins of Dengue, Zika, and Chikungunya viruses...
December 15, 2023: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38090579/genomic-annotation-for-vaccine-target-identification-and-immunoinformatics-guided-multi-epitope-based-vaccine-design-against-songling-virus-through-screening-its-whole-genome-encoded-proteins
#31
JOURNAL ARTICLE
S Luqman Ali, Awais Ali, Abdulaziz Alamri, Aliya Baiduissenova, Marat Dusmagambetov, Aigul Abduldayeva
Songling virus (SGLV), a newly discovered tick-borne orthonairovirus, was recently identified in human spleen tissue. It exhibits cytopathic effects in human hepatoma cells and is associated with clinical symptoms including headache, fever, depression, fatigue, and dizziness, but no treatments or vaccines exist for this pathogenic virus. In the current study, immunoinformatics techniques were employed to identify potential vaccine targets within SGLV by comprehensively analyzing SGLV proteins. Four proteins were chosen based on specific thresholds to identify B-cell and T-cell epitopes, validated through IFN-γ epitopes...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38085389/in-silico-design-of-an-epitope-based-vaccine-against-pspc-in-streptococcus-pneumoniae-using-reverse-vaccinology
#32
JOURNAL ARTICLE
Md Nahian, Muhammad Shahab, Lincon Mazumder, Jonas Ivan Nobre Oliveira, Tanjina Akhtar Banu, Murshed Hasan Sarkar, Barna Goswami, Ahashan Habib, Shamima Begum, Shahina Akter
BACKGROUND: Streptococcus pneumoniae is a major pathogen that poses a significant hazard to global health, causing a variety of infections including pneumonia, meningitis, and sepsis. The emergence of antibiotic-resistant strains has increased the difficulty of conventional antibiotic treatment, highlighting the need for alternative therapies such as multi-epitope vaccines. In this study, immunoinformatics algorithms were used to identify potential vaccine candidates based on the extracellular immunogenic protein Pneumococcal surface protein C (PspC)...
December 12, 2023: Journal, Genetic Engineering & Biotechnology
https://read.qxmd.com/read/38076796/vaxign-dl-a-deep-learning-based-method-for-vaccine-design-and-its-evaluation
#33
Yuhan Zhang, Anthony Huffman, Justin Johnson, Yongqun He
Reverse vaccinology (RV) provides a systematic approach to identifying potential vaccine candidates based on protein sequences. The integration of machine learning (ML) into this process has greatly enhanced our ability to predict viable vaccine candidates from these sequences. We have previously developed a Vaxign-ML program based on the eXtreme Gradient Boosting (XGBoost). In this study, we further extend our work to develop a Vaxign-DL program based on deep learning techniques. Deep neural networks assemble non-linear models and learn multilevel abstraction of data using hierarchically structured layers, offering a data-driven approach in computational design models...
December 1, 2023: bioRxiv
https://read.qxmd.com/read/38074091/immunoinformatics-and-reverse-vaccinology-approach-in-designing-a-novel-highly-immunogenic-multivalent-peptide-based-vaccine-against-the-human-monkeypox-virus
#34
JOURNAL ARTICLE
Abhigyan Choudhury, Anshuman Chandra, Turki M Dawoud, Hiba-Allah Nafidi, Nagendra Singh, Mohammed Bourhia
Background: Monkeypox is a highly infectious zoonotic disease, often resulting in complications ranging from respiratory illnesses to vision loss. The escalating global incidence of its cases demands prompt attention, as the absence of a proven post-exposure treatment underscores the criticality of developing an effective vaccine. Methods: Interactions of the viral proteins with TLR2 and TLR4 were investigated to assess their immunogenic potentials. Highly immunogenic proteins were selected and subjected to epitope mapping for identifying B-cell and MHC class I and II epitopes...
2023: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38055447/systematic-review-of-reverse-vaccinology-and-immunoinformatics-data-for-non-viral-sexually-transmitted-infections
#35
JOURNAL ARTICLE
Lucas Gabriel R Gomes, Joyce C F Dutra, Rodrigo Profeta, Mariana V Dias, Glen J Y García, Diego Lucas N Rodrigues, Aristóteles Goés Neto, Flávia F Aburjaile, Sandeep Tiwari, Siomar C Soares, Vasco Azevedo, Arun K Jaiswal
Sexually Transmitted Infections (STIs) are a public health burden rising in developed and developing nations. The World Health Organization estimates nearly 374 million new cases of curable STIs yearly. Global efforts to control their spread have been insufficient in fulfilling their objective. As there is no vaccine for many of these infections, these efforts are focused on education and condom distribution. The development of vaccines for STIs is vital for successfully halting their spread. The field of immunoinformatics is a powerful new tool for vaccine development, allowing for the identification of vaccine candidates within a bacterium's genome and allowing for the design of new genome-based vaccine peptides...
2023: Anais da Academia Brasileira de Ciências
https://read.qxmd.com/read/38055114/immunoinformatics-aided-rational-design-of-multiepitope-based-peptide-vaccine-mebv-targeting-human-parainfluenza-virus-3-hpiv-3-stable-proteins
#36
JOURNAL ARTICLE
Md Sakib Hossen, Md Nazmul Hasan, Munima Haque, Tawsif Al Arian, Sajal Kumar Halder, Md Jasim Uddin, M Abdullah-Al-Mamun, Md Salman Shakil
BACKGROUND: Human parainfluenza viruses (HPIVs) are common RNA viruses responsible for respiratory tract infections. Human parainfluenza virus 3 (HPIV-3) is particularly pathogenic, causing severe illnesses with no effective vaccine or therapy available. RESULTS: The current study employed a systematic immunoinformatic/reverse vaccinology approach to design a multiple epitope-based peptide vaccine against HPIV-3 by analyzing the virus proteome. On the basis of a number of therapeutic features, all three stable and antigenic proteins with greater immunological relevance, namely matrix protein, hemagglutinin neuraminidase, and RNA-directed RNA polymerase L, were chosen for predicting and screening suitable T-cell and B-cell epitopes...
December 6, 2023: Journal, Genetic Engineering & Biotechnology
https://read.qxmd.com/read/38051433/exploring-structural-antigens-of-yellow-fever-virus-to-design-multi-epitope-subunit-vaccine-candidate-by-utilizing-an-immuno-informatics-approach
#37
JOURNAL ARTICLE
Kiran Sura, Himanshi Rohilla, Dev Kumar, Ritu Jakhar, Vaishali Ahlawat, Deepshikha Kaushik, Mehak Dangi, Anil Kumar Chhillar
BACKGROUND: Yellow fever is a mosquito-borne viral hemorrhagic disease transmitted by several species of virus-infected mosquitoes endemic to tropical regions of Central and South America and Africa. Earlier in the twentieth century, mass vaccination integrated with mosquito control was implemented to eradicate the yellow fever virus. However, regular outbreaks occur in these regions which pose a threat to travelers and residents of Africa and South America. There is no specific antiviral therapy, but there can be an effective peptide-based vaccine candidate to combat infection caused by the virus...
December 5, 2023: Journal, Genetic Engineering & Biotechnology
https://read.qxmd.com/read/38035008/pangenomic-and-immunoinformatics-based-analysis-of-nipah-virus-revealed-cd4-and-cd8-t-cell-epitopes-as-potential-vaccine-candidates
#38
JOURNAL ARTICLE
Syed Aun Muhammad, Jinlei Guo, Komal Noor, Aymen Mustafa, Anam Amjad, Baogang Bai
Introduction: Nipah (NiV) is the zoonotic deadly bat-borne virus that causes neurological and respiratory infections which ultimately lead to death. There are 706 infected cases reported up till now especially in Asia, out of which 409 patients died. There is no vaccine and effective treatment available for NiV infections and we have to timely design such strategies as world could not bear another pandemic situation. Methods: In this study, we screened viral proteins of NiV strains based on pangenomics analysis, antigenicity, molecular weight, and sub-cellular localization...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/38028215/an-integrated-multi-pronged-reverse-vaccinology-and-biophysical-approaches-for-identification-of-potential-vaccine-candidates-against-nipah-virus
#39
JOURNAL ARTICLE
Aqel Albutti
Nipah virus, a paramyxovirus linked to Hendra virus that first appeared in Malaysia and is the etiological agent of viral lethal encephalitis, has emerged as a strong threat to the health community in recent decades. Viral infections are seriously affecting global health. Since there are now no efficient therapeutic options, it will take considerable effort to develop appropriate therapeutic management for the Nipah virus. The main purpose of this study was to design a messenger RNA-based multi-epitope vaccine construct against Nipah virus...
December 2023: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38024731/deciphering-the-immunogenicity-of-monkeypox-proteins-for-designing-the-potential-mrna-vaccine
#40
JOURNAL ARTICLE
Mohibullah Shah, Samavia Jaan, Muhammad Shehroz, Asifa Sarfraz, Khamna Asad, Tehreem Ul Wara, Aqal Zaman, Riaz Ullah, Essam A Ali, Umar Nishan, Suvash Chandra Ojha
The Monkeypox virus (MPXV), an orthopox virus, is responsible for monkeypox in humans, a zoonotic disease similar to smallpox. This infection first appeared in the 1970s in humans and then in 2003, after which it kept on spreading all around the world. To date, various antivirals have been used to cure this disease, but now, MPXV has developed resistance against these, thus increasing the need for an alternative cure for this deadly disease. In this study, we devised a reverse vaccinology approach against MPXV using a messenger RNA (mRNA) vaccine by pinning down the antigenic proteins of this virus...
November 14, 2023: ACS Omega
keyword
keyword
65369
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.